304 related articles for article (PubMed ID: 19770282)
1. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
Mwai L; Kiara SM; Abdirahman A; Pole L; Rippert A; Diriye A; Bull P; Marsh K; Borrmann S; Nzila A
Antimicrob Agents Chemother; 2009 Dec; 53(12):5069-73. PubMed ID: 19770282
[TBL] [Abstract][Full Text] [Related]
2. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
Tumwebaze P; Conrad MD; Walakira A; LeClair N; Byaruhanga O; Nakazibwe C; Kozak B; Bloome J; Okiring J; Kakuru A; Bigira V; Kapisi J; Legac J; Gut J; Cooper RA; Kamya MR; Havlir DV; Dorsey G; Greenhouse B; Nsobya SL; Rosenthal PJ
Antimicrob Agents Chemother; 2015; 59(6):3018-30. PubMed ID: 25753626
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
4. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
6. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
7. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
[TBL] [Abstract][Full Text] [Related]
8. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
9. In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Baraka V; Tinto H; Valea I; Fitzhenry R; Delgado-Ratto C; Mbonye MK; Van Overmeir C; Rosanas-Urgell A; Van Geertruyden JP; D'Alessandro U; Erhart A
Antimicrob Agents Chemother; 2015 Jan; 59(1):734-7. PubMed ID: 25403659
[TBL] [Abstract][Full Text] [Related]
10. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
11. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
12. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
13. Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.
Briolant S; Henry M; Oeuvray C; Amalvict R; Baret E; Didillon E; Rogier C; Pradines B
Antimicrob Agents Chemother; 2010 Sep; 54(9):3537-44. PubMed ID: 20547801
[TBL] [Abstract][Full Text] [Related]
14. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
15. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes.
Wang Z; Parker D; Meng H; Wu L; Li J; Zhao Z; Zhang R; Miao M; Fan Q; Wang H; Cui L; Yang Z
PLoS One; 2012; 7(5):e30927. PubMed ID: 22701513
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial activity of isoquine against Kenyan Plasmodium falciparum clinical isolates and association with polymorphisms in pfcrt and pfmdr1 genes.
Okombo J; Kiara SM; Abdirahman A; Mwai L; Ohuma E; Borrmann S; Nzila A; Ward S
J Antimicrob Chemother; 2013 Apr; 68(4):786-8. PubMed ID: 23169890
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
Shafik SH; Richards SN; Corry B; Martin RE
PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548
[TBL] [Abstract][Full Text] [Related]
19. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
[TBL] [Abstract][Full Text] [Related]
20. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
